Table 2.
Mortality odds ratios of preadmission clinical characteristics in hospitalized patients with diabetes and COVID-19 (N = 1,126)
| Unadjusted OR | Unadjusted 95% CI | Adjusted OR* | Adjusted 95% CI* | |
|---|---|---|---|---|
| Glycemic control: HbA1cƗ | 1.02 | 0.96, 1.08 | 1.01 | 0.94, 1.09 |
| Treatment regimen (Ref: no treatment) | ||||
| Noninsulin only | 1.45 | 1.00, 2.10 | 1.30 | 0.89, 1.91 |
| Insulin + noninsulin | 1.68 | 1.15, 2.45 | 1.74 | 1.13, 2.68 |
| Insulin only | 1.98 | 1.20, 3.26 | 2.30 | 1.32, 4.01 |
| Comorbidity or long-term diabetes complication | ||||
| Hypertension | 0.84 | 0.44, 1.58 | 0.54 | 0.28, 1.05 |
| Cardiovascular disease | 1.57 | 1.21, 2.04 | 1.18 | 0.88, 1.57 |
| Chronic kidney disease | 1.34 | 1.05, 1.72 | 1.11 | 0.84, 1.45 |
| Chronic obstructive pulmonary disease | 1.63 | 1.16, 2.29 | 1.46 | 1.02, 2.08 |
Ref, reference.
*
Adjustment: each variable was adjusted for age, sex, BMI, insurance, and the other variables in the table.
Ɨ
Most recent HbA1c within 3 years prior to or 1 week after hospitalization was used for analyses.